Eli Lilly expands sales on volume and access despite drug price declines
LLY Lilly(Eli) & Co
$1189.41 -3.59%
View chart & analysis → - 1Eli Lilly (LLY) shares up 78.5% over trailing 12 months... driven by volume and access expansion, not pricing
- 2US sales up 33% in Q2 2026 while prices fell 3%... Mounjaro and Zepbound global sales reach $14.9 billion
- 3CFO flags net price decline as CVS access expands in Q4... volume growth expected to more than offset
This 3-line summary is compiled from the report below.
Trefis +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다